These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 14999485)

  • 1. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of patients associated with anti-GM1b antibody].
    Tatsumoto M; Yuki N; Odaka M; Hirata K
    Rinsho Shinkeigaku; 2003 Apr; 43(4):149-53. PubMed ID: 12884824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
    Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
    Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
    Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
    Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
    Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
    Koga M; Yuki N; Hirata K
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
    Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
    J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
    Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
    Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
    Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
    Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
    Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
    Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J
    J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.